Mycophenolate mofetil-induced ischemic colitis.
Kim
H C
HC
Department of Internal Medicine, Keimyung University School of Medicine, Taegu, South Korea.
Park
S B
SB
D003092:Colitis / Q000139:chemically induced*; D003106:Colon / Q000098:blood supply; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007511:Ischemia / Q000139:chemically induced; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid; D016559:Tacrolimus